European journal of clinical pharmacy: atención farmacéutica

• 

  Año 2022, Vol. 24, Número 1

  • EDITORIAL

    • Possible elimination of dyslipidemia

      José Manuel López Tricas

      págs. 1-1

      

  • ORIGINAL

    • Assessment of drug-related problems among inpatients of general surgery department using aps-doc classification system

      Aparna Sajan, Ameena Sherin Pm, Stephen James Manjally, Abhijith S. Shetty, Nandakumar Up, Sharad Chand, Bharath Raj Kc

      • Resumen

      págs. 2-2

      

    • Assessment of the suitability of empirical levofloxacin according to the auc/mic parameter in hospitalized patients

      Carlos Devesa García, Francisco José Rodríguez Lucena, Gabriel Martínez Orea, Ana Candela Fajardo, N. Cano Cuenca, Rodrigo Bonilla Peñarrubia, Pablo Pérez Huertas, Elena Arroyo Domingo

      • Resumen

      págs. 3-3

      

    • Influence of trazodone on digoxin pharmacokinetics

      Emilio Monteagudo Santolaya, Ana Pelufo Pellicer, Álvaro Briz Redón, Agustín Sánchez Alcaraz, Miguel Murcia Soler, Mª J. Company Albir

      • Resumen

      págs. 4-4

      

  • REVIEWS

    • Pharmacologic agents, herbal and dietary supplements in the alleviation of electroconvulsive therapy induced cognitive disorder: A review of clinical studies

      Ali Kheradmand, Mohammad Abbasinazari

      • Resumen

      págs. 5-5

      

  • SHORT REPORTS

    • Serious disseminated intravascular coagulation in metastatic melanoma during second-line nivolumab monotherapy

      Bárbara Cancela Díez, Felix Gómez de Rueda, Ricardo Ruiz Villaverde, Isabel Moya Carmona

      • Resumen

      págs. 6-6

      

    • Intrathecal trastuzumab preparation for leptomeningeal carcinomatosis secondary to distal esophageal adenocarcinom

      Iván González Barrios, Susana Cortijo Cascajares, Beatriz Sánchez Sanz, M. P. Goyache-Goñi, Flora López López, Carlos Gómez Martín, José Antonio Hernández Ramos, José Miguel Ferrari Piquero

      • Resumen

      págs. 7-7

      

    • Assessment of patients over 80 years of age under treatment with medications for bone mineralization

      María Victoria Muñoz Arroyo

      • Resumen

      págs. 8-8